Beqvez (previously Durveqtix): New gene therapy treatment for haemophilia B received approval from the European Commission

After a positive draft opinion by the Committee for Advanced Therapies (CAT) on 24 May 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion on Beqvez (previously Durveqtix) the 30 May. Following the CHMP opinion, the 24 July 2024, the European Commission granted a conditional marketing authorisation to this new treatment for adults with severe or moderately severe haemophilia B. More information on this newly authorised medicines on the EMA Website.

Publication Details

Journal
Industrias Culturais (Universidade de Coimbra)
Published
2024-10-25
DOI
https://doi.org/10.58079/12ksg
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beqvez (previously Durveqtix): New gene therapy treatment for haemophilia B received approval from the European Commission

Industrias Culturais (Universidade de Coimbra)
Hemophilia Treatment and Research
article

Beqvez (previously Durveqtix): New gene therapy treatment for haemophilia B received approval from the European Commission

article en

Abstract

After a positive draft opinion by the Committee for Advanced Therapies (CAT) on 24 May 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion on Beqvez (previously Durveqtix) the 30 May. Following the CHMP opinion, the 24 July 2024, the European Commission granted a conditional marketing authorisation to this new treatment for adults with severe or moderately severe haemophilia B. More information on this newly authorised medicines on the EMA Website.

Industrias Culturais (Universidade de Coimbra)
Good health and well-being
Openalex Percentile: Top 46%
Hemophilia Treatment and Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Beqvez (previously Durveqtix): New gene therapy treatment for haemophilia B received approval from the European Commission · Industrias Culturais (Universidade de Coimbra) (2024) | TGRS Research Map | TGRS